Advocating for a cure for Herpes Simplex Virus.
Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
Despite the fact that 48% of people between 14 and 49 in the US are infected with HSV 1, and one in eight adults is infected with HSV-2, many people living with herpes do not feel confident in their health care provider’s ability to help them manage the virus. A 2024 HCA survey of patientsContinue reading "How Clinicians and Patients Talk about Herpes: Bridging the Disconnect"
Join us as we host Assembly Bio for an in-depth discussion on recurrent genital herpes (RGH). This talk will provide an overview of RGH epidemiology, real-world disease burden, and impact on affected individuals. We will review the current treatment landscape and patient journey, highlight the state of clinical science, and discuss the rationale for advancingContinue reading "Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation."